Revista de Hematología

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board

>Journals >Revista de Hematología >Year 2016, Issue 2

Moraleda-Jiménez JM
The relation between drug companies and the physicians. Is it possible to have it healthy and clear?
Rev Hematol Mex 2016; 17 (2)

Language: Español
References: 7
Page: 77-80
PDF: 349.22 Kb.

Full text

Text Extraction

No abstract.

Key words: No keywords


  1. Campbell EG, Gruen RL, Mountford J, Miller LG, et al. A national survey of physician-industry relationships. N Engl J Med 2007;356:1742-1750.

  2. Brennan TA, Rothman DJ, Blank L, et al. Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA 2006;295:429-433.

  3. Campbell EG. Doctors and drug companies: scrutinizing influential relationships. N Engl J Med 2007;357:1796-1797.

  4. Ruiz Argüelles GJ. A new breed in the teaching of medicine: paid lecturers, trainers or speakers? Acta Haematol 2016;135:191-192.

  5. Gomez Córdoba AI, Latorre Santos C, Nel Carreño J. Dilemas éticos en las relaciones entre la industria farmacéutica y los profesionales de la salud. Persona y bioética 2007;11:23-38.

  6. Ramchandren R, Schiffer CA, et al. ReCAP: pattern of duplicate presentations at national hemato-oncology meetings: influence of the pharmaceutical industry. J Oncol Pract 2016;12:252-253.

  7. Código de Buenas Prácticas de la Industria Farmacéutica 2014. Disponible en: http://www.farmaindustria.es/idc/ groups/public/documents/publicaciones/FARMA_123819. pdf

>Journals >Revista de Hematología >Year 2016, Issue 2

· Journal Index 
· Links 

Copyright 2019